2021
DOI: 10.1155/2021/8952048
|View full text |Cite
|
Sign up to set email alerts
|

A Case Report of Subacute Thyroiditis following mRNA COVID-19 Vaccine

Abstract: Background. Subacute thyroiditis has been reported after administration of influenza vaccine. We describe a case of a patient who developed subacute thyroiditis after administration of. Moderna mRNA COVID-19 vaccine. Case Presentation. A 42-year-old female, with a past medical history of stage IIIB pT3N1aM0 right adenocarcinoma of colon status, after right hemicolectomy on 01/2020, followed by adjuvant chemotherapy, paroxysmal supraventricular tachycardia, iron deficiency anemia, chemotherapy-induced neuropath… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0
1

Year Published

2022
2022
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(13 citation statements)
references
References 5 publications
(8 reference statements)
0
12
0
1
Order By: Relevance
“…In response to the worldwide spread of the COVID-19 pandemic, several vaccine preparations have been developed, including mRNA-based SARS-CoV-2 vaccines (BNT162b2-Pfizer-BioNTech and mRNA-1273-Moderna), an inactivated SARS-CoV-2 vaccine (CoronaVac-Sinovac Life Sciences), and viral vector vaccines (ChAdOx1 nCoV-19-Oxford-AstraZeneca and Ad26.COV2.S-Janssen-Johnson & Johnson). Several cases of SAT triggered by different types of COVID-19 vaccines have already been described [9][10][11][12][13][14][15][16][17][18][19]. However, taking into account the number of 9.79 billion doses of COVID-19 vaccines administered worldwide, SAT appears to be a rare side effect of vaccination.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In response to the worldwide spread of the COVID-19 pandemic, several vaccine preparations have been developed, including mRNA-based SARS-CoV-2 vaccines (BNT162b2-Pfizer-BioNTech and mRNA-1273-Moderna), an inactivated SARS-CoV-2 vaccine (CoronaVac-Sinovac Life Sciences), and viral vector vaccines (ChAdOx1 nCoV-19-Oxford-AstraZeneca and Ad26.COV2.S-Janssen-Johnson & Johnson). Several cases of SAT triggered by different types of COVID-19 vaccines have already been described [9][10][11][12][13][14][15][16][17][18][19]. However, taking into account the number of 9.79 billion doses of COVID-19 vaccines administered worldwide, SAT appears to be a rare side effect of vaccination.…”
Section: Discussionmentioning
confidence: 99%
“…Up to January 2022, 9.79 billion doses have been administered globally [8]. Several reports of SAT after various types of COVID-19 vaccines have already been published [9][10][11][12][13][14][15][16][17][18][19]. Rare cases of SAT triggered by other vaccinations have been described before, mainly in regard to influenza or hepatitis B vaccines [20,21].…”
Section: Introductionmentioning
confidence: 99%
“…To date, a total of 16 reports with 22 SAT cases after vaccination against COVID-19 have been reported. 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 The clinical features of each patient, including our patient, are summarized in Table 1 . Six types of vaccines have been reported to be associated with SAT: AstraZeneca (6 cases), 2 4 8 9 13 CoronaVac (5 cases), 6 14 15 Pfizer-BioNTech (4 cases), 5 7 11 16 Moderna (3 cases), 2 12 Janssen (1 case), 8 Covaxin (1 case) 17 and cases that did not include the type of vaccine (3 cases).…”
Section: Discussionmentioning
confidence: 99%
“… 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 The clinical features of each patient, including our patient, are summarized in Table 1 . Six types of vaccines have been reported to be associated with SAT: AstraZeneca (6 cases), 2 4 8 9 13 CoronaVac (5 cases), 6 14 15 Pfizer-BioNTech (4 cases), 5 7 11 16 Moderna (3 cases), 2 12 Janssen (1 case), 8 Covaxin (1 case) 17 and cases that did not include the type of vaccine (3 cases). 3 10 There were more cases of SAT after the first dose (13/23 cases) than after the second dose (10/23 cases).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation